Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Amortization of Deferred Charges (2016 - 2025)

Rockwell Medical (RMTI) has disclosed Amortization of Deferred Charges for 10 consecutive years, with $89000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Amortization of Deferred Charges rose 1.14% year-over-year to $89000.0, compared with a TTM value of $354000.0 through Sep 2025, down 69.69%, and an annual FY2024 reading of $426000.0, down 61.52% over the prior year.
  • Amortization of Deferred Charges was $89000.0 for Q3 2025 at Rockwell Medical, up from $88000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $831000.0 in Q4 2023 and bottomed at $30000.0 in Q2 2024.
  • Average Amortization of Deferred Charges over 5 years is $133473.7, with a median of $92000.0 recorded in 2021.
  • The sharpest move saw Amortization of Deferred Charges surged 793.55% in 2023, then crashed 89.29% in 2024.
  • Year by year, Amortization of Deferred Charges stood at $93000.0 in 2021, then changed by 0.0% to $93000.0 in 2022, then soared by 793.55% to $831000.0 in 2023, then plummeted by 89.29% to $89000.0 in 2024, then changed by 0.0% to $89000.0 in 2025.
  • Business Quant data shows Amortization of Deferred Charges for RMTI at $89000.0 in Q3 2025, $88000.0 in Q2 2025, and $88000.0 in Q1 2025.